Biopharmaceutical firm Attralus has completed a $25 million Series A financing designed to further validate its AT-01 pan-amyloid radiotracer for PET/CT. Led by venBio Partners, the infusion is also intended to advance two therapeutic candidates, AT-02 and AT-03, into clinical development for ATTR (transthyretin), AL (light chain), and potentially, ALECT 2 systemic amyloidosis. Amyloidosis is

Contrast-enhanced ultrasound (CEUS) helps physicians accurately diagnose some forms of liver cancer more safely and less expensively than computed tomography (CT) and magnetic resonance (MR), according to a report  published earlier this month in Hepatoma Research. CEUS shows “comparable performance with CT and MR for liver mass characterization and prediction of malignancy,” lead author Stephanie

“If a piezoelectric detector was miniaturized to the scale of SWED, it would be 100 million times less sensitive,” Shnaiderman says. SWED was originally developed for use in optoacoustic imaging, but the team has already identified other imaging and sensing applications for the technology, along with industrial uses. Shnaiderman and his team plan to first test

Both MRI and CT images were reviewed by a radiologist with 10 years of experience. Five patients were found to have typical CT features, with ground glass opacities and consolidations, readily visible on different MRI sequences. Three patients had indeterminate or atypical features that were also easily seen using the MRI modality. “Our preliminary data

The FDA has granted RadLogics 510(k) clearance for its AI-Powered chest x-ray pneumothorax application, the company announced Tuesday. Operating in tandem with existing workflow applications, the application, which is trained via pattern recognition, leverages an AI algorithm to analyze images for features that suggest the presence of pneumothorax. It then makes case-level output available to

In addition, among women with high socioeconomic status, 11.7% of Black women experienced delays in initiating treatment. Far fewer white women in this group (6.7%) were noted to have had the same. “Even among women with low socioeconomic status, we still saw fewer delays among white women, underscoring the disparate experience of Black women, who

Thirdly, while POCUS utilization changed diagnosis, plan and/or treatment for most patients, the project did not follow patients to see if these changes improved care quality or undermined it.   Still, given the fast scans and reads along with the resulting care-path changes, the use of POCUS is “feasible in general practice despite differences in

Overall, the algorithm predicted osteoarthritis with 78% accuracy from MRIs performed three years before symptom onset, picking up signs of the disease that are too subtle to register in radiologists’ eyes. Currently, there are no drugs that prevent presymptomatic osteoarthritis from developing into full-blown joint deterioration, but drugs that can prevent patients from developing a

The researchers also theorized that isolated REM sleep behavior disorder (iRBD) is a prodromal phenotype for the body-first variant. Per Borghammer, PhD, Jacob Morsager, MD, and colleagues chose 37 consecutive de novo Parkinson’s patients for a case-control PET study. Of these, 24 patients were RBD-negative and 13 were RBD-positive. A comparator group comprised 22 iRBD

All studies were evaluated for arterial or venous thromboembolism, the presence of which, when identified, was confirmed by two abdominal radiologists. Patients’ EMRs were reviewed for inflammatory markers, hospital course and, in those with thromboembolic findings, other hypercoagulability risk factors. Thromboembolic findings were discovered in nine patients (11%) with COVID-19; of these patients, five had